{"url":"https://lda.senate.gov/api/v1/filings/29dfd171-7d22-47ad-bc76-db3bd866f059/","filing_uuid":"29dfd171-7d22-47ad-bc76-db3bd866f059","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2017,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/29dfd171-7d22-47ad-bc76-db3bd866f059/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Ladd Wiley","dt_posted":"2018-01-19T11:47:08.033000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 New Hampshire Avenue, NW","registrant_address_2":"Suite 500","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":30212,"url":"https://lda.senate.gov/api/v1/registrants/30212/","house_registrant_id":30804,"name":"OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC","description":"Law Firm, Government Relations","address_1":"2000 Pennsylvania Avenue NW","address_2":"Suite 4003","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ROGER SZEMRAJ","contact_telephone":"+1 202-412-7311","dt_updated":"2026-07-01T08:36:02.651295-04:00"},"client":{"id":135716,"url":"https://lda.senate.gov/api/v1/clients/135716/","client_id":1005460,"name":"GILEAD SCIENCES","general_description":"Innovative Biopharmaceutical Company","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-06-12"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S. 3506); PEPFAR","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66146,"prefix":null,"prefix_display":null,"first_name":"LADD","nickname":null,"middle_name":null,"last_name":"WILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":44092,"prefix":"mr","prefix_display":"MR.","first_name":"ROGER","nickname":null,"middle_name":"R","last_name":"SZEMRAJ","suffix":null,"suffix_display":null},"covered_position":"House Approps Committee; CoS of Rep. Marcy Kaptur","new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}